Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2007 2
2008 5
2009 4
2010 6
2011 3
2012 2
2013 9
2014 12
2015 15
2016 17
2017 13
2018 17
2019 30
2020 23
2021 35
2022 35
2023 33
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Results by year

Filters applied: . Clear all
Page 1
Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis.
Su Y, Luo Y, Zhang P, Lin H, Pu W, Zhang H, Wang H, Hao Y, Xiao Y, Zhang X, Wei X, Nie S, Zhang K, Fu Q, Chen H, Huang N, Ren Y, Wu M, Chow BKC, Chen X, Jin W, Wang F, Zhao L, Rao F. Su Y, et al. Among authors: hao y. Mol Cell. 2023 Jul 6;83(13):2316-2331.e7. doi: 10.1016/j.molcel.2023.06.010. Epub 2023 Jun 29. Mol Cell. 2023. PMID: 37390815
Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression.
Hu J, Wang SG, Hou Y, Chen Z, Liu L, Li R, Li N, Zhou L, Yang Y, Wang L, Wang L, Yang X, Lei Y, Deng C, Li Y, Deng Z, Ding Y, Kuang Y, Yao Z, Xun Y, Li F, Li H, Hu J, Liu Z, Wang T, Hao Y, Jiao X, Guan W, Tao Z, Ren S, Chen K. Hu J, et al. Among authors: hao y. Nat Genet. 2024 Mar;56(3):442-457. doi: 10.1038/s41588-024-01662-5. Epub 2024 Feb 15. Nat Genet. 2024. PMID: 38361033 Free PMC article.
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo SW, Bistran-Hall AJ, Gandhi D, Mould WA, Ullman N, Ali H, Carhuapoma JR, Kase CS, Lees KR, Dawson J, Wilson A, Betz JF, Sugar EA, Hao Y, Avadhani R, Caron JL, Harrigan MR, Carlson AP, Bulters D, LeDoux D, Huang J, Cobb C, Gupta G, Kitagawa R, Chicoine MR, Patel H, Dodd R, Camarata PJ, Wolfe S, Stadnik A, Money PL, Mitchell P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum JS, Wang W, Anderson CS, Mendelow AD, Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad IA; MISTIE III Investigators. Hanley DF, et al. Among authors: hao y. Lancet. 2019 Mar 9;393(10175):1021-1032. doi: 10.1016/S0140-6736(19)30195-3. Epub 2019 Feb 7. Lancet. 2019. PMID: 30739747 Free PMC article. Clinical Trial.
Novel delivery approaches for cancer therapeutics.
Mitra AK, Agrahari V, Mandal A, Cholkar K, Natarajan C, Shah S, Joseph M, Trinh HM, Vaishya R, Yang X, Hao Y, Khurana V, Pal D. Mitra AK, et al. Among authors: hao y. J Control Release. 2015 Dec 10;219:248-268. doi: 10.1016/j.jconrel.2015.09.067. Epub 2015 Oct 9. J Control Release. 2015. PMID: 26456750 Free PMC article. Review.
Adaptive therapy: a tumor therapy strategy based on Darwinian evolution theory.
Zhang L, Ma J, Liu L, Li G, Li H, Hao Y, Zhang X, Ma X, Chen Y, Wu J, Wang X, Yang S, Xu S. Zhang L, et al. Among authors: hao y. Crit Rev Oncol Hematol. 2023 Dec;192:104192. doi: 10.1016/j.critrevonc.2023.104192. Epub 2023 Oct 28. Crit Rev Oncol Hematol. 2023. PMID: 37898477 Free article. Review.
246 results